Vault-13

Column Group LLC

San Francisco, CA · CIK 1833486 · 13F filing filed 2023-07-24

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$257.7m reported value -6.8% vs Q1 2023
7positions
100.0%in top 10
0 new 1 added 1 reduced 0 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 REVOLUTION MEDICINES INC COM RVMD RVMD 2,577,220 $68.9m26.76% 26.76% ReducedShares held: Q3 2022 4.6m, Q4 2022 4.6m, Q1 2023 4.6m, Q2 2023 2.6m -2.0m -2,000,620 -43.7%
2 TENAYA THERAPEUTICS INC COM TNYA TNYA 9,400,290 $55.2m21.42% 21.42% UnchangedShares held: Q3 2022 9.4m, Q4 2022 9.4m, Q1 2023 9.4m, Q2 2023 9.4m
3 RAPT THERAPEUTICS INC COM COM 2,680,621 $50.1m19.45% 19.45% UnchangedShares held: Q3 2022 2.7m, Q4 2022 2.7m, Q1 2023 2.7m, Q2 2023 2.7m
4 NGM BIOPHARMACEUTICALS INC COM NGM NGM 18,136,735 $47.0m18.23% 18.23% UnchangedShares held: Q3 2022 18.1m, Q4 2022 18.1m, Q1 2023 18.1m, Q2 2023 18.1m
5 ORIC PHARMACEUTICALS INC COM ORIC ORIC 3,568,181 $27.7m10.75% 10.75% UnchangedShares held: Q3 2022 3.6m, Q4 2022 3.6m, Q1 2023 3.6m, Q2 2023 3.6m
6 SURROZEN INC COM COM 9,414,795 $5.2m2.01% 2.01% AddedShares held: Q3 2022 9.2m, Q4 2022 9.4m, Q1 2023 9.2m, Q2 2023 9.4m +166.7k +166,666 1.8%
7 EFFECTOR THERAPEUTICS INC COM COM 4,309,329 $3.6m1.39% 1.39% UnchangedShares held: Q3 2022 4.3m, Q4 2022 4.3m, Q1 2023 4.3m, Q2 2023 4.3m